Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
View Patent ↗The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
1. A compound of structural Formula (I):
or a salt thereof, wherein:
R 1 , R 2 , R 3 and R 4 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl, substituted heteroarylalkyl, halogen, hydroxy, or nitro;
R 5 and R 6 each represent independently for each occurrence hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl, substituted heteroarylalkyl, halogen, hydroxy, or nitro;
R 7 is
a substituted acyl selected from the group consisting of substituted —C(O)-cycloalkyl, substituted —C(O)-aryl, substituted —C(O)-arylalkyl, substituted —C(O)-heteroaryl, substituted —C(O)-heteroarylalkyl, and an —C(O)-alkyl substituted by one or more substituents independently selected from the group consisting of halogen, —OR 60 , —SR 60 , —CF 3 , —OS(O) 2 R 60 , —OP(O)(OR 60 )(OR 61 ), and —OP(O)(OH) 2 ;
R 60 represents independently for each occurrence alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
R 61 represents independently for each occurrence hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
o is 0, 1, 2, 3 or 4; and
provided that at least two of R 1 , R 2 , R 3 , R 4 , —R 5 and R 6 are nitro.
2. The compound of claim 1 , wherein two of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are nitro.
3. The compound of claim 1 , wherein R 1 , R 2 , and R 3 are each independently hydrogen, alkyl, aryl, or nitro; and R 5 and R 6 each represent independently for each occurrence hydrogen, alkyl, aryl, or nitro.
4. The compound of claim 2 , wherein R 1 , R 2 , and R 3 are each independently hydrogen, alkyl, aryl, or nitro; and R 5 and R 6 each represent independently for each occurrence hydrogen, alkyl, aryl, or nitro.
5. The compound of claim 1 , wherein R 3 is nitro; and R 1 , R 2 , R 4 , R 5 , and R 6 each represent independently for each occurrence hydrogen, alkyl, aryl, or nitro.
6. The compound of claim 2 , wherein R 3 is nitro; and R 1 , R 2 , R 4 , R 5 , and R 6 each represent independently for each occurrence hydrogen, alkyl, aryl, or nitro.
7. The compound of claim 1 , wherein R 3 and R 4 are nitro; and R 1 , R 2 , R 5 , and R 6 each represent independently for each occurrence hydrogen, alkyl, or aryl.
8. The compound of claim 2 , wherein R 3 and R 4 are nitro; and R 1 , R 2 , R 5 , and R 6 each represent independently for each occurrence hydrogen or alkyl.
9. The compound of claim 1 , wherein R 7 is —C(O)-cycloalkyl, —C(O)-arylalkyl, —C(O)-heteroarylalkyl, or —C(O)-alkyl, each of which is substituted by one or more substituents independently selected from the group consisting of halogen, —OR 60 , and —OS(O) 2 R 60 .
10. The compound of claim 4 , wherein R 7 is —C(O)-cycloalkyl, —C(O)-arylalkyl, —C(O)-heteroarylalkyl, or —C(O)-alkyl, each of which is substituted by one or more substituents independently selected from the group consisting of halogen, —OR 60 , and —OS(O) 2 R 60 .
11. The compound of claim 1 , wherein R 7 is —C(O)-arylalkyl or —C(O)-alkyl, each of which is substituted by one or more substituents independently selected from the group consisting of halogen, —OR 60 , and —OS(O) 2 R 60 ; and R 60 is alkyl, substituted alkyl, aryl, or substituted aryl.
12. The compound of claim 4 , wherein R 7 is —C(O)-arylalkyl or —C(O)-alkyl, each of which is substituted by one or more substituents independently selected from the group consisting of halogen, —OR 60 , and —OS(O) 2 R 60 ; and R 60 is alkyl, substituted alkyl, aryl, or substituted aryl.
13. The compound of claim 1 , wherein R 7 is —C(O)-alkyl substituted with a halogen.
14. The compound of claim 4 , wherein R 7 is —C(O)-alkyl substituted with a halogen.
15. The compound of claim 1 , wherein R 7 is —C(O)—CH 3 substituted with a halogen.
16. The compound of claim 4 , wherein R 7 is —C(O)—CH 3 substituted with a halogen.
17. The compound of claim 8 , wherein R 7 is —C(O)—CH 3 substituted with a halogen.
18. The compound of claim 1 , wherein variable o is 2 or 3.
19. The compound of claim 4 , wherein variable o is 2 or 3.
20. The compound of claim 17 , wherein variable o is 2 or 3.
21. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable vehicle.
22. A compound of structural Formula (I):
or a salt thereof, wherein:
R 1 , R 2 , R 3 and R 4 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl, substituted heteroarylalkyl, halogen, hydroxy, or nitro;
R 5 and R 6 each represent independently for each occurrence hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl, substituted heteroarylalkyl, halogen, hydroxy, or nitro;
R 7 is —C(O)-alkyl substituted by one or more substituents independently selected from the group consisting of halogen, —OR 60 , —SR 60 , —CF 3 , —OS(O) 2 R 60 , —OP(O)(OR 60 )(OR 61 ), and —OP(O)(OH) 2 ;
R 60 represents independently for each occurrence alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
R 61 represents independently for each occurrence hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
o is 0, 1, 2, 3 or 4; and
provided that at least one of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are nitro.
23. A pharmaceutical composition comprising a compound of claim 22 and a pharmaceutically acceptable vehicle.